☆ 4.6 Article

Downregulation of cellular retinoic acid binding protein 1 fosters epithelial-mesenchymal transition in thyroid cancer

MOLECULAR CARCINOGENESIS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Trends in thyroid cancer burden in Taiwan over two decades

Sheena Yi-Hsin Cheng et al.

Summary: The incidence rates of thyroid cancer in Taiwan have been steadily increasing over the past two decades, with significant upward trends observed in all age groups. While the mortality rate from thyroid cancer has decreased in women, it has remained stable in men.

CANCER CAUSES & CONTROL (2023)

Add to Collection

Article Endocrinology & Metabolism

Upregulation of dendrocyte-expressed seven transmembrane protein is associated with unfavorable outcomes in differentiated thyroid cancer

Jie-Jen Lee et al.

Summary: This study identified DCSTAMP as a prognostic gene involved in dendritic cell differentiation for thyroid cancer. DCSTAMP was found to be overexpressed in various types of thyroid cancers and associated with poor clinical outcomes. Further studies are needed to explore the potential immunomodulatory role of DCSTAMP in thyroid cancer.

ENDOCRINE (2023)

Add to Collection

Article Oncology

SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway

Chi-Yu Kuo et al.

Summary: Aberrant lipid metabolism plays a crucial role in providing energy, building materials, and oxidative stress resistance to cancer cells. This study found that high expression of SREBP1 in invasive thyroid cancer is associated with extrathyroidal extension, advanced disease stage, and shorter disease-specific survival. SREBP1 overexpression promotes cancer cell invasiveness through the upregulation of CYR61/CTGF via the Hippo-YAP pathway.

ENDOCRINE-RELATED CANCER (2022)

Add to Collection

Article Immunology

Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification

Yi Chen et al.

Summary: Through studying the transcriptome features of endometrial cancer patients, we identified T follicular helper-like cells (Tfh) as an important factor with potential clinical application in anti-PD-1 treatment. We constructed a Tfh Infiltration Risk Model (TIRM) and found that it outperformed existing models in predicting the prognosis of EC patients.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer

Kazuki Sakata et al.

Summary: This study found that CRABP1 plays a promoting role in gastric cancer cells and may serve as a biomarker for predicting recurrence, especially peritoneal dissemination, after curative surgery.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Add to Collection

Review Nutrition & Dietetics

CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases

Jennifer Nhieu et al.

Summary: Cellular Retinoic Acid Binding Protein 1 (CRABP1) plays an important role as a mediator of non-canonical activities of retinoic acid and is associated with stem cell proliferation, cancers, adipocyte health, neuro-immune regulation, heart, and motor neuron diseases. Abnormal CRABP1 is potentially associated with human diseases such as cancer, neurodegenerative diseases, and immune diseases.

NUTRIENTS (2022)

Add to Collection

Article Nutrition & Dietetics

Transcriptomic Characteristics Associated With Aging in the Thyroid Gland

Chien-Liang Liu et al.

Summary: This study analyzed RNA sequencing data of normal thyroid tissues and identified gene expression changes associated with aging. The findings shed light on molecular mechanisms underlying thyroid disorders in the geriatric population.

FRONTIERS IN NUTRITION (2022)

Add to Collection

Article Endocrinology & Metabolism

PDZK1 Interacting Protein 1 Promotes the Progression of Papillary Thyroid Cancer

Kun Wang et al.

Summary: This study identified 39 differentially expressed genes (DEGs) associated with the progression of papillary thyroid cancer (PTC), among which PDZK1IP1 was found to be upregulated both at the mRNA and protein levels. High expression of PDZK1IP1 was associated with poor progression-free survival, lymph node metastasis, and other clinical characteristics in PTC. Functionally, PDZK1IP1 promoted proliferation and inhibited apoptosis of PTC cells, suggesting its role as an oncogene and potential therapeutic target in PTC.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Article Cell Biology

Aberrant Expression of Thymosin Beta-4 Correlates With Advanced Disease and BRAF V600E Mutation in Thyroid Cancer

Chi-Yu Kuo et al.

Summary: This study found that TMSB4X expression was aberrantly increased in various types of thyroid cancer, and higher expression was correlated with advanced disease characteristics.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2022)

Add to Collection

Article Endocrinology & Metabolism

CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin/FAK/AKT Pathway

Chien-Liang Liu et al.

Summary: CRABP2 expression is upregulated in thyroid cancer and associated with adverse prognosis. CRABP2 expression is related to the invasion capacity of thyroid cancer cells and may promote invasion through the integrin/focal adhesion kinase/AKT pathway.

ENDOCRINOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells

Shou-Sen Huang et al.

Summary: This study found that ACLY expression is increased in anaplastic thyroid cancer. ACLY inhibitors can suppress the growth, clonogenic ability, and invasion of thyroid cancer cells and promote cell apoptosis. In addition, ACLY inhibitors can enhance the cytotoxicity of sorafenib. Therefore, targeting ACLY may be a novel therapeutic strategy for thyroid cancer.

ENDOCRINE (2022)

Add to Collection

Article Pathology

IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis

Jacob Haase et al.

Summary: ATC can be distinguished from other types of thyroid carcinoma by the protein expression of IGF2BP1 and MAGEA3, with 75% of ATC samples showing IGF2BP1 protein positive while only 0.5% of other types of thyroid carcinoma showing this protein positive, making IGF2BP1 an important marker for auxiliary diagnosis.

MODERN PATHOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo

Hannah M. Hicks et al.

Summary: Mutations in the BRAF gene are common in thyroid cancer, with mixed responses to BRAF-directed therapies. Combination therapies targeting the MAPK pathway at multiple nodes, such as BRAF and ERK1/2 inhibition, have shown promise in overcoming resistance and enhancing tumor growth inhibition, clonogenic survival decrease, and apoptosis induction in BRAF-mutant thyroid cancer cells. This study supports the potential of combined BRAF and ERK1/2 inhibition as an alternative therapeutic strategy for advanced thyroid cancer patients.

MOLECULAR CARCINOGENESIS (2021)

Add to Collection

Review Medicine, General & Internal

Retinoic Acids in the Treatment of Most Lethal Solid Cancers

Lara Costantini et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Oncology

Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer

Shih-Ping Cheng et al.

JOURNAL OF PATHOLOGY (2020)

Add to Collection

Article Oncology

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

Inigo Landa et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Review Biochemistry & Molecular Biology

All-trans Retinoic Acid as a Versatile Cytosolic Signal Modulator Mediated by CRABP1

Isha Nagpal et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Multidisciplinary Sciences

A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1

Sung Wook Park et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Oncology

PGC1α downregulation and glycolytic phenotype in thyroid cancer

Chien-Liang Liu et al.

JOURNAL OF CANCER (2019)

Add to Collection

Article Oncology

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension

Ricardo Celestino et al.

BMC CANCER (2018)

Add to Collection

Review Oncology

Response of Retinoic Acid in Patients with Radioactive Iodine-Refractory Thyroid Cancer: A Meta-Analysis

Kyoungjune Pak et al.

ONCOLOGY RESEARCH AND TREATMENT (2018)

Add to Collection

Article Biochemistry & Molecular Biology

CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid

Rong-Zong Liu et al.

MOLECULAR CANCER (2015)

Add to Collection

Article Oncology

miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression

Nahyun Choi et al.

ONCOTARGET (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal et al.

CELL (2014)

Add to Collection

Article Cell Biology

CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors

Yaroslav Kainov et al.

CELL CYCLE (2014)

Add to Collection

Article Cell Biology

Cellular retinoic acid binding protein I mediates rapid non-canonical activation of ERK1/2 by all-trans retinoic acid

Shawna D. Persaud et al.

CELLULAR SIGNALLING (2013)

Add to Collection

Article Endocrinology & Metabolism

DNA Methylation Signatures Identify Biologically Distinct Thyroid Cancer Subtypes

Sandra Rodriguez-Rodero et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Add to Collection

Article Biochemistry & Molecular Biology

A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic

G. Tomas et al.

ONCOGENE (2012)

Add to Collection

Article Oncology

Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer

E. E. Vincent et al.

BRITISH JOURNAL OF CANCER (2011)

Add to Collection

Article Cell Biology

How phosphorylation controls p53

Nicola J. MacLaine et al.

CELL CYCLE (2011)

Add to Collection

Article Oncology

CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma

Takahito Miyake et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)

Add to Collection

Article Oncology

Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas

J. M. Pita et al.

BRITISH JOURNAL OF CANCER (2009)

Add to Collection

Article Anatomy & Morphology

A Bioinformatics Approach for Identifying Candidate Transcriptional Regulators of Mesenchyme-to-Epithelium Transitions in Mouse Embryos

Jonathan B. L. Bard et al.

DEVELOPMENTAL DYNAMICS (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma

K. Tanaka et al.

ONCOGENE (2007)

Add to Collection

Article Oncology

Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype

Wilma C. G. van Staveren et al.

CANCER RESEARCH (2007)

Add to Collection

Article Oncology

Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A

Michael W. Yeh et al.

ENDOCRINE-RELATED CANCER (2006)

Add to Collection

Article Oncology

Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers

Obi L. Griffith et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Add to Collection

Article Biology

CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation

MA Blaese et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2003)

Add to Collection

Article Oncology

Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma

Y Huang et al.

INTERNATIONAL JOURNAL OF CANCER (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.